Management and Monitoring of Pregnancy in Women with Undifferentiated Connective Tissue Dysplasia (UCTD)

Abstract

Undifferentiated connective tissue dysplasia (UCTD) is a complex and often under- recognized condition that presents with features of autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis, but does not meet the full diagnostic criteria for any specific disease[1]. Pregnancy in women with UCTD carries both maternal and fetal risks, including hypertension, miscarriage, preeclampsia, and fetal growth restriction. This article examines the pathophysiology, clinical management, and essential care strategies for women with UCTD during pregnancy[2]. A multidisciplinary approach, including regular monitoring, pharmacologic treatment, and collaborative care, is crucial to improve outcomes for both the mother and fetus[3].